Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts
- PMID: 19074954
- DOI: 10.1093/ije/dyn261
Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts
Abstract
Background: In 2004-05, Georgia experienced large-scale concurrent measles and rubella outbreaks. We analysed measles and rubella epidemiology in Georgia to describe disease trends, determine the cause of the outbreaks, identify challenges to achieving disease elimination goals and propose interventions to overcome them.
Methods: We reviewed national measles and rubella surveillance and vaccination coverage data, focusing on the 2004-05 outbreaks, and conducted a measles vaccine effectiveness (VE) study using data from a 2004 school-based outbreak.
Results: Before 2004, the last large measles outbreak after measles vaccination was introduced (in 1966) in Georgia, was in 1988 (incidence rate, 36/100 000); the highest year for rubella was 1985 (110/100 000). During 2004-05, 8391 measles cases and 5151 rubella cases were reported (most of them diagnosed clinically). Of 358 suspected measles cases tested, 181 (51%) were positive for measles-IgM antibody; of 240 suspected rubella cases tested, 50 (21%) were positive for rubella-IgM antibody. Over 90% of measles cases were in persons born after 1979; 90% of rubella cases were in persons born after 1987. Approximately 41% of measles cases and 88% of rubella cases were unvaccinated. Estimated measles VE (>/=1 vs 0 doses) was 86% (95% CI, 58-96%).
Conclusions: The outbreak likely resulted from failure to vaccinate rather than vaccine failure. Susceptible persons likely accumulated due to the long absence of large outbreaks and decreased coverage after the collapse of Soviet Union. To interrupt measles and rubella transmission in Georgia and achieve disease elimination goals by 2010, supplementary immunization activities should target children and young adults.
Similar articles
-
Progress toward measles and rubella elimination in Egypt.J Infect Dis. 2011 Jul;204 Suppl 1:S318-24. doi: 10.1093/infdis/jir123. J Infect Dis. 2011. PMID: 21666180
-
Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.Risk Anal. 2017 Jun;37(6):1109-1131. doi: 10.1111/risa.12831. Epub 2017 May 31. Risk Anal. 2017. PMID: 28561947
-
Surveillance and vaccination coverage of measles and rubella in Northern Italy.Hum Vaccin Immunother. 2015;11(1):206-13. doi: 10.4161/hv.35865. Epub 2014 Nov 1. Hum Vaccin Immunother. 2015. PMID: 25483537 Free PMC article.
-
Measles, mumps, rubella prevention: how can we do better?Expert Rev Vaccines. 2021 Jul;20(7):811-826. doi: 10.1080/14760584.2021.1927722. Epub 2021 Jun 7. Expert Rev Vaccines. 2021. PMID: 34096442 Review.
-
MMR vaccination and disease elimination: the Finnish experience.Expert Rev Vaccines. 2010 Sep;9(9):1045-53. doi: 10.1586/erv.10.99. Expert Rev Vaccines. 2010. PMID: 20822347 Review.
Cited by
-
Measles and rubella seroprevalence among adults in Georgia in 2015: helping guide the elimination efforts.Epidemiol Infect. 2019 Dec 11;147:e319. doi: 10.1017/S0950268819002048. Epidemiol Infect. 2019. PMID: 31822310 Free PMC article.
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2020 Apr 20;4(4):CD004407. doi: 10.1002/14651858.CD004407.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Nov 22;11:CD004407. doi: 10.1002/14651858.CD004407.pub5. PMID: 32309885 Free PMC article. Updated.
-
Evaluation of the Bio-Rad BioPlex Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG multiplex bead immunoassay.Clin Vaccine Immunol. 2011 Sep;18(9):1524-6. doi: 10.1128/CVI.05207-11. Epub 2011 Jul 27. Clin Vaccine Immunol. 2011. PMID: 21795463 Free PMC article.
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD004407. doi: 10.1002/14651858.CD004407.pub5. Cochrane Database Syst Rev. 2021. PMID: 34806766 Free PMC article.
-
Vaccines for measles, mumps and rubella in children.Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD004407. doi: 10.1002/14651858.CD004407.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2020 Apr 20;4:CD004407. doi: 10.1002/14651858.CD004407.pub4. PMID: 22336803 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical